Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics - ScienceDirect
Effects of the Kappa Agonist U69,593 on Naltrexone's Discriminative Stimulus Effect in Subjects Given Chronic, Intermittent Sucrose Access
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Representative examples of common scaffolds in kappa opioid receptor... | Download Scientific Diagram
The Kappa Opioid Receptor | SpringerLink
Nalfurafine, a G-Protein–Biased KOR (Kappa Opioid Receptor) Agonist, Enhances the Diuretic Response and Limits Electrolyte Losses to Standard-of-Care Diuretics | Hypertension
HZ2, a Selective Kappa‐Opioid Agonist - Kögel - 1998 - CNS Drug Reviews - Wiley Online Library
greenscreen Xylazine is an agonist on the kappa receptor. Keep giving... | TikTok
Mu Agonist Opioids and Kappa Opioids | Download Table
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Kappa opioid receptor (KOR) modulation of dopamine in the cortex and... | Download Scientific Diagram
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Opioid Receptor | kappa, mu Opioid Receptor
Kappa Receptors – Opioid Peptides
Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience
κ-Opioid Receptor (KOP) | 7TM Antibodies
Kappa opioid receptor (KOR) activation study. A): G protein activation... | Download Scientific Diagram
Can Kappa and Alpha-2 Agonist Agents Treat Opioid-Induced Ventilatory Depression Risk While Preserving Analgesic Effects? – Consult QD